White House Government Agencies

More

  • NEW YORK, Oct 26- Global equity markets slipped on Monday, pausing after a four-week rally ahead of policy announcements from central banks in the United States and Japan later in the week, while the dollar weakened in the wake of soft U.S. housing data. Stock markets rallied last week on the potential that Japan's already-massive stimulus would be further...

  • Oct 26- A U.S. judge on Monday expressed strong doubts that he had the legal authority to order Apple Inc to access data on a locked iPhone that was seized as part of a federal investigation. Magistrate Judge James Orenstein told government attorneys at a hearing in Brooklyn federal court. Orenstein asked Apple and the U.S. Justice Department for arguments on the...

  • Oct 26- U.S. federal prosecutors are preparing to announce criminal charges against a former Goldman Sachs banker alleged to have obtained confidential documents from the Federal Reserve Bank of New York, a person familiar with matter said on Monday. Separately, the New York Department of Financial Services is looking at fining Goldman Sachs $50 million and...

  • NEW YORK, Oct 26- Global equity markets edged lower on Monday, pausing after a four-week rally ahead of policy announcements from central banks in the U.S. and Japan later in the week, while the dollar lost ground in the wake of soft U.S. housing data. Stock markets rallied last week on bets that Japan's already-massive stimulus would be further increased after...

  • Oct 26- U.S. health regulators said on Monday that there was no evidence of increased cardiovascular risks related to Novartis AG's treatment, Stalevo, for Parkinson's disease. Recommendations for using the drug, which won U.S. approval in 2003, will remain the same on the labels, the U.S. Food and Drug Administration said, after examining data from a required...

  • Oct 26- U.S. federal prosecutors are planning to announce a criminal case this week against a former Goldman Sachs Group Inc banker suspected of taking confidential documents from a government employee, the New York Times reported. When Bansal joined Goldman in July 2014, he was assigned to advise one of the same banks he had previously regulated when he worked...

  • NEW YORK, Oct 26- The dollar fell from a 2-1/ 2- month high versus a basket of major currencies on Monday on lower U.S. bond yields and a drop in U.S. new home sales in September that revived concerns about the U.S. economy before a two-day Federal Reserve policy meeting. The dollar index just booked its best week since mid-May as investor sentiment improved following...

  • NEW YORK, Oct 26- Global equity markets slipped on Monday, pausing after a four-week rally ahead of policy announcements from central banks in the U.S. and Japan later in the week, while the dollar lost ground in the wake of soft U.S. housing data. Investors had recently raised bets that Japan's already-massive stimulus would be further increased after China cut...

  • Oct 26- U.S. stocks were little changed on Monday ahead of this week's Federal Reserve policy meeting and quarterly earnings reports from key companies including Apple.

  • *Gold still not far from near two-week lows. LONDON, Oct 26- Gold inched up on Monday after a three-day losing streak, as the dollar's ascent paused and uncertainty persisted over the timing of the first Federal Reserve rate increase in a decade. Gold had risen 1 percent soon after China's surprise interest rate cut on Friday, as investors bet the U.S. central bank...

  • Oct 26- BioDelivery Sciences International Inc said the U.S. Food and Drug Administration had approved its opioid treatment for chronic pain, sending the drugmaker's shares up 19 percent in premarket trading on Monday. Endo International Plc licensed the worldwide manufacturing and marketing rights to the treatment, Belbuca, from BioDelivery in 2012..

  • BioDelivery's opioid treatment wins FDA approval Monday, 26 Oct 2015 | 6:15 AM ET

    Oct 26- The U.S. Food and Drug Administration has approved BioDelivery Sciences International Inc's opioid treatment for chronic pain, the company said on Monday. Endo International Plc licensed the worldwide manufacturing and marketing rights to the treatment, Belbuca, from BioDelivery in 2012.. Belbuca is an opioid film patch and aims to treat patients...

  • SAN FRANCISCO, Oct 26- Federal Reserve Chair Janet Yellen, praised as an adept listener and consensus builder, may need to adopt a stronger tone at this week's policy meeting if she expects to keep a December interest rate rise in play. Yellen's inclusive style has been tested recently by two fellow governors who publicly appeared to disagree with her view, shared...

  • Paul Thompson, one of seven Rabobank traders indicted in New York, has been scheduled to appear in Magistrates Court of Western Australia on Oct. 28 following his arrest in the state capital Perth on Thursday, the official said. Thompson was the Dutch bank's head of money market and derivatives trading for Northeast Asia, according to a U.S. Justice Department...

  • SINGAPORE, Oct 26- Gold was hovering close to its lowest in nearly two weeks on Monday, hurt by a stronger dollar and fears the Federal Reserve could raise U.S. interest rates this year. *Spot gold eased 0.1 percent to $1,162.25 an ounce by 0035 GMT. *On Friday, the metal had initially risen 1 percent after China cut interest rates for the sixth time in less than a year.

  • Oct 23- The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's Strensiq, a treatment for a rare kind of metabolic bone disorder. The approval is the first in the United States for a treatment for perinatal, infantile and juvenile-onset hypophosphatasia. The debilitating disorder affects fewer than 200,000 patients in the...

  • CHICAGO, Oct 23- The U.S. Department of Agriculture on Friday signed off on a new genetically modified type of corn developed by Monsanto Co after a review concluded it posed no significant threat to agricultural crops, other plants or the environment. The USDA's Animal and Plant Health Inspection Service announced it would deregulate Monsanto's MON 87411...

  • Oct 23- The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's Strensiq, a treatment for a rare kind of metabolic disorder.

  • Oct 23- An independent panel of advisers to the U.S. Food and Drug Administration on Friday voted 10-4 in favor of approving AstraZeneca Plc's gout drug. All 10 who backed the drug, lesinurad, qualified their vote by urging the FDA to ask AstraZeneca for studies after the drug's launch to gauge its long-term effectiveness and safety. AstraZeneca said, if approved,...

  • Oct 23- An independent panel of advisers to the U.S. Food and Drug Administration on Friday voted in favor of approving AstraZeneca Plc's gout drug, lesinurad. The panel voted 10 to 4 in favor of approval. The recommendation follows comments from the FDA's staff on Wednesday, which raised questions about the drug's benefit-risk profile, pointing specifically to...